<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2005-12-20" modified="2019-09-18" version="130">
<accession>P0AEK4</accession>
<accession>P29132</accession>
<name>FABI_ECOLI</name>
<protein>
<recommendedName>
<fullName>Enoyl-[acyl-carrier-protein] reductase [NADH] FabI</fullName>
<shortName>ENR</shortName>
<ecNumber>1.3.1.9</ecNumber>
</recommendedName>
<alternativeName>
<fullName>NADH-dependent enoyl-ACP reductase</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">fabI</name>
<name type="synonym">envM</name>
<name type="ordered locus">b1288</name>
<name type="ordered locus">JW1281</name>
</gene>
<organism>
<name type="scientific">Escherichia coli (strain K12)</name>
<dbReference type="NCBI Taxonomy" id="83333"/>
<lineage>
<taxon>Bacteria</taxon>
<taxon>Proteobacteria</taxon>
<taxon>Gammaproteobacteria</taxon>
<taxon>Enterobacterales</taxon>
<taxon>Enterobacteriaceae</taxon>
<taxon>Escherichia</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1992" name="J. Gen. Microbiol." volume="138" first="2093" last="2100">
<title>Sequences of the envM gene and of two mutated alleles in Escherichia coli.</title>
<authorList>
<person name="Bergler H."/>
<person name="Hoegenauer G."/>
<person name="Turnowsky F."/>
</authorList>
<dbReference type="PubMed" id="1364817"/>
<dbReference type="DOI" id="10.1099/00221287-138-10-2093"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>PROTEIN SEQUENCE OF 2-31</scope>
<scope>MUTAGENESIS OF GLY-93</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1994" name="Plant Mol. Biol." volume="25" first="771" last="790">
<title>The use of a hybrid genetic system to study the functional relationship between prokaryotic and plant multi-enzyme fatty acid synthetase complexes.</title>
<authorList>
<person name="Kater M.M."/>
<person name="Koningstein G.M."/>
<person name="Nijkamp H.J.J."/>
<person name="Stuitje A.R."/>
</authorList>
<dbReference type="PubMed" id="8075395"/>
<dbReference type="DOI" id="10.1007/bf00028873"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<source>
<strain>K12 / W3110 / ATCC 27325 / DSM 5911</strain>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="1996" name="DNA Res." volume="3" first="363" last="377">
<title>A 570-kb DNA sequence of the Escherichia coli K-12 genome corresponding to the 28.0-40.1 min region on the linkage map.</title>
<authorList>
<person name="Aiba H."/>
<person name="Baba T."/>
<person name="Fujita K."/>
<person name="Hayashi K."/>
<person name="Inada T."/>
<person name="Isono K."/>
<person name="Itoh T."/>
<person name="Kasai H."/>
<person name="Kashimoto K."/>
<person name="Kimura S."/>
<person name="Kitakawa M."/>
<person name="Kitagawa M."/>
<person name="Makino K."/>
<person name="Miki T."/>
<person name="Mizobuchi K."/>
<person name="Mori H."/>
<person name="Mori T."/>
<person name="Motomura K."/>
<person name="Nakade S."/>
<person name="Nakamura Y."/>
<person name="Nashimoto H."/>
<person name="Nishio Y."/>
<person name="Oshima T."/>
<person name="Saito N."/>
<person name="Sampei G."/>
<person name="Seki Y."/>
<person name="Sivasundaram S."/>
<person name="Tagami H."/>
<person name="Takeda J."/>
<person name="Takemoto K."/>
<person name="Takeuchi Y."/>
<person name="Wada C."/>
<person name="Yamamoto Y."/>
<person name="Horiuchi T."/>
</authorList>
<dbReference type="PubMed" id="9097039"/>
<dbReference type="DOI" id="10.1093/dnares/3.6.363"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
<source>
<strain>K12 / W3110 / ATCC 27325 / DSM 5911</strain>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="1997" name="Science" volume="277" first="1453" last="1462">
<title>The complete genome sequence of Escherichia coli K-12.</title>
<authorList>
<person name="Blattner F.R."/>
<person name="Plunkett G. III"/>
<person name="Bloch C.A."/>
<person name="Perna N.T."/>
<person name="Burland V."/>
<person name="Riley M."/>
<person name="Collado-Vides J."/>
<person name="Glasner J.D."/>
<person name="Rode C.K."/>
<person name="Mayhew G.F."/>
<person name="Gregor J."/>
<person name="Davis N.W."/>
<person name="Kirkpatrick H.A."/>
<person name="Goeden M.A."/>
<person name="Rose D.J."/>
<person name="Mau B."/>
<person name="Shao Y."/>
</authorList>
<dbReference type="PubMed" id="9278503"/>
<dbReference type="DOI" id="10.1126/science.277.5331.1453"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
<source>
<strain>K12 / MG1655 / ATCC 47076</strain>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="2006" name="Mol. Syst. Biol." volume="2" first="E1" last="E5">
<title>Highly accurate genome sequences of Escherichia coli K-12 strains MG1655 and W3110.</title>
<authorList>
<person name="Hayashi K."/>
<person name="Morooka N."/>
<person name="Yamamoto Y."/>
<person name="Fujita K."/>
<person name="Isono K."/>
<person name="Choi S."/>
<person name="Ohtsubo E."/>
<person name="Baba T."/>
<person name="Wanner B.L."/>
<person name="Mori H."/>
<person name="Horiuchi T."/>
</authorList>
<dbReference type="PubMed" id="16738553"/>
<dbReference type="DOI" id="10.1038/msb4100049"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
<source>
<strain>K12 / W3110 / ATCC 27325 / DSM 5911</strain>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="1994" name="J. Biol. Chem." volume="269" first="5493" last="5496">
<title>Protein EnvM is the NADH-dependent enoyl-ACP reductase (FabI) of Escherichia coli.</title>
<authorList>
<person name="Bergler H."/>
<person name="Wallner P."/>
<person name="Ebeling A."/>
<person name="Leitinger B."/>
<person name="Fuchsbichler S."/>
<person name="Aschauer H."/>
<person name="Kollenz G."/>
<person name="Hoegenauer G."/>
<person name="Turnowsky F."/>
</authorList>
<dbReference type="PubMed" id="8119879"/>
</citation>
<scope>PARTIAL PROTEIN SEQUENCE</scope>
<scope>FUNCTION AS AN ENOYL-ACP REDUCTASE</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
<scope>ACTIVITY REGULATION</scope>
</reference>
<reference key="7">
<citation type="journal article" date="1997" name="Electrophoresis" volume="18" first="1259" last="1313">
<title>Comparing the predicted and observed properties of proteins encoded in the genome of Escherichia coli K-12.</title>
<authorList>
<person name="Link A.J."/>
<person name="Robison K."/>
<person name="Church G.M."/>
</authorList>
<dbReference type="PubMed" id="9298646"/>
<dbReference type="DOI" id="10.1002/elps.1150180807"/>
</citation>
<scope>PROTEIN SEQUENCE OF 2-13</scope>
<source>
<strain>K12 / EMG2</strain>
</source>
</reference>
<reference key="8">
<citation type="submission" date="1996-02" db="UniProtKB">
<authorList>
<person name="Frutiger S."/>
<person name="Hughes G.J."/>
<person name="Pasquali C."/>
<person name="Hochstrasser D.F."/>
</authorList>
</citation>
<scope>PROTEIN SEQUENCE OF 2-12</scope>
<source>
<strain>K12 / W3110 / ATCC 27325 / DSM 5911</strain>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="1995" name="J. Biol. Chem." volume="270" first="26538" last="26542">
<title>Enoyl-acyl carrier protein reductase (fabI) plays a determinant role in completing cycles of fatty acid elongation in Escherichia coli.</title>
<authorList>
<person name="Heath R.J."/>
<person name="Rock C.O."/>
</authorList>
<dbReference type="PubMed" id="7592873"/>
<dbReference type="DOI" id="10.1074/jbc.270.44.26538"/>
</citation>
<scope>FUNCTION IN FATTY ACID BIOSYNTHESIS</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1998" name="Nature" volume="394" first="531" last="532">
<title>Triclosan targets lipid synthesis.</title>
<authorList>
<person name="McMurry L.M."/>
<person name="Oethinger M."/>
<person name="Levy S.B."/>
</authorList>
<dbReference type="PubMed" id="9707111"/>
<dbReference type="DOI" id="10.1038/28970"/>
</citation>
<scope>ACTIVITY REGULATION</scope>
<scope>MUTAGENESIS OF GLY-93; MET-159 AND PHE-203</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2010" name="Bioorg. Med. Chem. Lett." volume="20" first="56" last="59">
<title>Novel enoyl-ACP reductase (FabI) potential inhibitors of Escherichia coli from Chinese medicine monomers.</title>
<authorList>
<person name="Yao J."/>
<person name="Zhang Q."/>
<person name="Min J."/>
<person name="He J."/>
<person name="Yu Z."/>
</authorList>
<dbReference type="PubMed" id="19959361"/>
<dbReference type="DOI" id="10.1016/j.bmcl.2009.11.042"/>
</citation>
<scope>ACTIVITY REGULATION</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2010" name="Nat. Chem. Biol." volume="6" first="682" last="688">
<title>Biotin synthesis begins by hijacking the fatty acid synthetic pathway.</title>
<authorList>
<person name="Lin S."/>
<person name="Hanson R.E."/>
<person name="Cronan J.E."/>
</authorList>
<dbReference type="PubMed" id="20693992"/>
<dbReference type="DOI" id="10.1038/nchembio.420"/>
</citation>
<scope>FUNCTION IN BIOTIN BIOSYNTHESIS</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1996" name="Science" volume="274" first="2107" last="2110">
<title>A mechanism of drug action revealed by structural studies of enoyl reductase.</title>
<authorList>
<person name="Baldock C."/>
<person name="Rafferty J.B."/>
<person name="Sedelnikova S.E."/>
<person name="Baker P.J."/>
<person name="Stuitje A.R."/>
<person name="Slabas A.R."/>
<person name="Hawkes T.R."/>
<person name="Rice D.W."/>
</authorList>
<dbReference type="PubMed" id="8953047"/>
<dbReference type="DOI" id="10.1126/science.274.5295.2107"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) IN COMPLEX WITH NAD AND INHIBITOR</scope>
<scope>ACTIVITY REGULATION</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1999" name="Biochemistry" volume="38" first="12514" last="12525">
<title>Kinetic and structural characteristics of the inhibition of enoyl (acyl carrier protein) reductase by triclosan.</title>
<authorList>
<person name="Ward W.H."/>
<person name="Holdgate G.A."/>
<person name="Rowsell S."/>
<person name="McLean E.G."/>
<person name="Pauptit R.A."/>
<person name="Clayton E."/>
<person name="Nichols W.W."/>
<person name="Colls J.G."/>
<person name="Minshull C.A."/>
<person name="Jude D.A."/>
<person name="Mistry A."/>
<person name="Timms D."/>
<person name="Camble R."/>
<person name="Hales N.J."/>
<person name="Britton C.J."/>
<person name="Taylor I.W."/>
</authorList>
<dbReference type="PubMed" id="10493822"/>
<dbReference type="DOI" id="10.1021/bi9907779"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) IN COMPLEX WITH NAD AND INHIBITOR</scope>
<scope>ACTIVITY REGULATION</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="15">
<citation type="journal article" date="1999" name="J. Mol. Biol." volume="290" first="859" last="865">
<title>Structural basis and mechanism of enoyl reductase inhibition by triclosan.</title>
<authorList>
<person name="Stewart M.J."/>
<person name="Parikh S."/>
<person name="Xiao G."/>
<person name="Tonge P.J."/>
<person name="Kisker C."/>
</authorList>
<dbReference type="PubMed" id="10398587"/>
<dbReference type="DOI" id="10.1006/jmbi.1999.2907"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) IN COMPLEX WITH NAD AND INHIBITOR</scope>
<scope>ACTIVITY REGULATION</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="16">
<citation type="journal article" date="1999" name="Nature" volume="398" first="383" last="384">
<title>Molecular basis of triclosan activity.</title>
<authorList>
<person name="Levy C.W."/>
<person name="Roujeinikova A."/>
<person name="Sedelnikova S."/>
<person name="Baker P.J."/>
<person name="Stuitje A.R."/>
<person name="Slabas A.R."/>
<person name="Rice D.W."/>
<person name="Rafferty J.B."/>
</authorList>
<dbReference type="PubMed" id="10201369"/>
<dbReference type="DOI" id="10.1038/18803"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) IN COMPLEX WITH NAD AND INHIBITOR</scope>
</reference>
<reference key="17">
<citation type="journal article" date="1999" name="Protein Sci." volume="8" first="2529" last="2532">
<title>Molecular basis for triclosan activity involves a flipping loop in the active site.</title>
<authorList>
<person name="Qiu X."/>
<person name="Janson C.A."/>
<person name="Court R.I."/>
<person name="Smyth M.G."/>
<person name="Payne D.J."/>
<person name="Abdel-Meguid S.S."/>
</authorList>
<dbReference type="PubMed" id="10595560"/>
<dbReference type="DOI" id="10.1110/ps.8.11.2529"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) IN COMPLEX WITH NAD AND INHIBITOR</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2001" name="Bioorg. Med. Chem. Lett." volume="11" first="2061" last="2065">
<title>1,4-Disubstituted imidazoles are potential antibacterial agents functioning as inhibitors of enoyl acyl carrier protein reductase (FabI).</title>
<authorList>
<person name="Heerding D.A."/>
<person name="Chan G."/>
<person name="DeWolf W.E."/>
<person name="Fosberry A.P."/>
<person name="Janson C.A."/>
<person name="Jaworski D.D."/>
<person name="McManus E."/>
<person name="Miller W.H."/>
<person name="Moore T.D."/>
<person name="Payne D.J."/>
<person name="Qiu X."/>
<person name="Rittenhouse S.F."/>
<person name="Slater-Radosti C."/>
<person name="Smith W."/>
<person name="Takata D.T."/>
<person name="Vaidya K.S."/>
<person name="Yuan C.C."/>
<person name="Huffman W.F."/>
</authorList>
<dbReference type="PubMed" id="11514139"/>
<dbReference type="DOI" id="10.1016/s0960-894x(01)00404-8"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) IN COMPLEX WITH NAD AND INHIBITOR</scope>
<scope>ACTIVITY REGULATION</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2002" name="J. Med. Chem." volume="45" first="3246" last="3256">
<title>Discovery of aminopyridine-based inhibitors of bacterial enoyl-ACP reductase (FabI).</title>
<authorList>
<person name="Miller W.H."/>
<person name="Seefeld M.A."/>
<person name="Newlander K.A."/>
<person name="Uzinskas I.N."/>
<person name="Burgess W.J."/>
<person name="Heerding D.A."/>
<person name="Yuan C.C."/>
<person name="Head M.S."/>
<person name="Payne D.J."/>
<person name="Rittenhouse S.F."/>
<person name="Moore T.D."/>
<person name="Pearson S.C."/>
<person name="Berry V."/>
<person name="DeWolf W.E. Jr."/>
<person name="Keller P.M."/>
<person name="Polizzi B.J."/>
<person name="Qiu X."/>
<person name="Janson C.A."/>
<person name="Huffman W.F."/>
</authorList>
<dbReference type="PubMed" id="12109908"/>
<dbReference type="DOI" id="10.1021/jm020050+"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) IN COMPLEX WITH NAD AND INHIBITOR</scope>
<scope>ACTIVITY REGULATION</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2003" name="J. Med. Chem." volume="46" first="1627" last="1635">
<title>Indole naphthyridinones as inhibitors of bacterial enoyl-ACP reductases FabI and FabK.</title>
<authorList>
<person name="Seefeld M.A."/>
<person name="Miller W.H."/>
<person name="Newlander K.A."/>
<person name="Burgess W.J."/>
<person name="DeWolf W.E. Jr."/>
<person name="Elkins P.A."/>
<person name="Head M.S."/>
<person name="Jakas D.R."/>
<person name="Janson C.A."/>
<person name="Keller P.M."/>
<person name="Manley P.J."/>
<person name="Moore T.D."/>
<person name="Payne D.J."/>
<person name="Pearson S."/>
<person name="Polizzi B.J."/>
<person name="Qiu X."/>
<person name="Rittenhouse S.F."/>
<person name="Uzinskas I.N."/>
<person name="Wallis N.G."/>
<person name="Huffman W.F."/>
</authorList>
<dbReference type="PubMed" id="12699381"/>
<dbReference type="DOI" id="10.1021/jm0204035"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.33 ANGSTROMS) IN COMPLEX WITH NAD AND INHIBITOR</scope>
<scope>ACTIVITY REGULATION</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="39285" last="39293">
<title>Structure of acyl carrier protein bound to FabI, the FASII enoyl reductase from Escherichia coli.</title>
<authorList>
<person name="Rafi S."/>
<person name="Novichenok P."/>
<person name="Kolappan S."/>
<person name="Zhang X."/>
<person name="Stratton C.F."/>
<person name="Rawat R."/>
<person name="Kisker C."/>
<person name="Simmerling C."/>
<person name="Tonge P.J."/>
</authorList>
<dbReference type="PubMed" id="17012233"/>
<dbReference type="DOI" id="10.1074/jbc.m608758200"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS)</scope>
<scope>MUTAGENESIS OF TYR-146; TYR-156; LYS-201; ARG-204 AND LYS-205</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
</reference>
<comment type="function">
<text evidence="16 17 18">Catalyzes the reduction of a carbon-carbon double bond in an enoyl moiety that is covalently linked to an acyl carrier protein (ACP). Involved in the elongation cycle of fatty acid which are used in the lipid metabolism and in the biotin biosynthesis.</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="18">
<text>a 2,3-saturated acyl-[ACP] + NAD(+) = a (2E)-enoyl-[ACP] + H(+) + NADH</text>
<dbReference type="Rhea" id="RHEA:10240"/>
<dbReference type="Rhea" id="RHEA-COMP:9925"/>
<dbReference type="Rhea" id="RHEA-COMP:9926"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:57540"/>
<dbReference type="ChEBI" id="CHEBI:57945"/>
<dbReference type="ChEBI" id="CHEBI:78784"/>
<dbReference type="ChEBI" id="CHEBI:78785"/>
<dbReference type="EC" id="1.3.1.9"/>
</reaction>
</comment>
<comment type="activity regulation">
<text evidence="7 8 10 11 12 15 18 19 21">Inhibited by diazaborines, triclosan (5-chloro-2-2,4-dichlorophenoxyphenol), 1,4-disubstituted imidazoles, 1,4-benzodiazepine derivatives, naphthyridinone derivatives, luteolin and curcumin.</text>
</comment>
<comment type="biophysicochemical properties">
<kinetics>
<KM evidence="14 18">3.3 uM for trans-2-dodecenoyl-ACP (DD-ACP)(at 25 degrees Celsius and pH 8)</KM>
<KM evidence="14 18">22 uM for crotonyl-ACP (at 30 degrees Celsius and pH 7.5)</KM>
<KM evidence="14 18">24 uM for trans-2-dodecenoyl-CoA (DD-CoA)(at 25 degrees Celsius and pH 8)</KM>
<KM evidence="14 18">2700 uM for crotonyl-CoA (at 30 degrees Celsius and pH 7.5)</KM>
</kinetics>
</comment>
<comment type="pathway">
<text>Lipid metabolism; fatty acid biosynthesis.</text>
</comment>
<comment type="pathway">
<text>Cofactor biosynthesis; biotin biosynthesis.</text>
</comment>
<comment type="subunit">
<text evidence="6 7 8 9 10 11 12 19">Homotetramer.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-370029"/>
<interactant intactId="EBI-544031">
<id>P0AF90</id>
<label>rraB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="miscellaneous">
<text>The antibiotic diazaborine interferes with the activity by binding to the protein and NAD.</text>
</comment>
<comment type="similarity">
<text evidence="23">Belongs to the short-chain dehydrogenases/reductases (SDR) family. FabI subfamily.</text>
</comment>
<dbReference type="EC" id="1.3.1.9"/>
<dbReference type="EMBL" id="M97219">
<property type="protein sequence ID" value="AAA17755.1"/>
<property type="molecule type" value="Unassigned_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X78733">
<property type="protein sequence ID" value="CAA55381.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U00096">
<property type="protein sequence ID" value="AAC74370.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AP009048">
<property type="protein sequence ID" value="BAA14841.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="PIR" id="S48029">
<property type="entry name" value="S48029"/>
</dbReference>
<dbReference type="RefSeq" id="NP_415804.1">
<property type="nucleotide sequence ID" value="NC_000913.3"/>
</dbReference>
<dbReference type="RefSeq" id="WP_000506490.1">
<property type="nucleotide sequence ID" value="NZ_STEB01000005.1"/>
</dbReference>
<dbReference type="PDB" id="1C14">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A/B=1-262"/>
</dbReference>
<dbReference type="PDB" id="1D8A">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A/B=2-262"/>
</dbReference>
<dbReference type="PDB" id="1DFG">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A/B=2-262"/>
</dbReference>
<dbReference type="PDB" id="1DFH">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A/B=2-262"/>
</dbReference>
<dbReference type="PDB" id="1DFI">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.09"/>
<property type="chains" value="A/B/C/D=2-262"/>
</dbReference>
<dbReference type="PDB" id="1I2Z">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A/B=1-262"/>
</dbReference>
<dbReference type="PDB" id="1I30">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A/B=1-262"/>
</dbReference>
<dbReference type="PDB" id="1LX6">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A/B=1-262"/>
</dbReference>
<dbReference type="PDB" id="1LXC">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A/B=1-262"/>
</dbReference>
<dbReference type="PDB" id="1MFP">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.33"/>
<property type="chains" value="A/B=1-262"/>
</dbReference>
<dbReference type="PDB" id="1QG6">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A/B/C/D=2-262"/>
</dbReference>
<dbReference type="PDB" id="1QSG">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.75"/>
<property type="chains" value="A/B/C/D/E/F/G/H=1-262"/>
</dbReference>
<dbReference type="PDB" id="2FHS">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A/B=1-262"/>
</dbReference>
<dbReference type="PDB" id="3PJD">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A/B=1-262"/>
</dbReference>
<dbReference type="PDB" id="3PJE">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A/B=1-262"/>
</dbReference>
<dbReference type="PDB" id="3PJF">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A/B=1-262"/>
</dbReference>
<dbReference type="PDB" id="4JQC">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A/B=1-262"/>
</dbReference>
<dbReference type="PDB" id="4JX8">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.20"/>
<property type="chains" value="A/B=1-262"/>
</dbReference>
<dbReference type="PDB" id="5CFZ">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.97"/>
<property type="chains" value="A/B=1-262"/>
</dbReference>
<dbReference type="PDB" id="5CG1">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.07"/>
<property type="chains" value="A/B=1-262"/>
</dbReference>
<dbReference type="PDB" id="5CG2">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.11"/>
<property type="chains" value="A/B=1-262"/>
</dbReference>
<dbReference type="PDBsum" id="1C14"/>
<dbReference type="PDBsum" id="1D8A"/>
<dbReference type="PDBsum" id="1DFG"/>
<dbReference type="PDBsum" id="1DFH"/>
<dbReference type="PDBsum" id="1DFI"/>
<dbReference type="PDBsum" id="1I2Z"/>
<dbReference type="PDBsum" id="1I30"/>
<dbReference type="PDBsum" id="1LX6"/>
<dbReference type="PDBsum" id="1LXC"/>
<dbReference type="PDBsum" id="1MFP"/>
<dbReference type="PDBsum" id="1QG6"/>
<dbReference type="PDBsum" id="1QSG"/>
<dbReference type="PDBsum" id="2FHS"/>
<dbReference type="PDBsum" id="3PJD"/>
<dbReference type="PDBsum" id="3PJE"/>
<dbReference type="PDBsum" id="3PJF"/>
<dbReference type="PDBsum" id="4JQC"/>
<dbReference type="PDBsum" id="4JX8"/>
<dbReference type="PDBsum" id="5CFZ"/>
<dbReference type="PDBsum" id="5CG1"/>
<dbReference type="PDBsum" id="5CG2"/>
<dbReference type="SMR" id="P0AEK4"/>
<dbReference type="BioGrid" id="4260135">
<property type="interactions" value="290"/>
</dbReference>
<dbReference type="DIP" id="DIP-31867N"/>
<dbReference type="IntAct" id="P0AEK4">
<property type="interactions" value="12"/>
</dbReference>
<dbReference type="STRING" id="511145.b1288"/>
<dbReference type="BindingDB" id="P0AEK4"/>
<dbReference type="ChEMBL" id="CHEMBL1857"/>
<dbReference type="ChEMBL" id="CHEMBL2364678"/>
<dbReference type="DrugBank" id="DB04030">
<property type="generic name" value="1,3,4,9-Tetrahydro-2-(Hydroxybenzoyl)-9-[(4-Hydroxyphenyl)Methyl]-6-Methoxy-2h-Pyrido[3,4-B]Indole"/>
</dbReference>
<dbReference type="DrugBank" id="DB08265">
<property type="generic name" value="2-(TOLUENE-4-SULFONYL)-2H-BENZO[D][1,2,3]DIAZABORININ-1-OL"/>
</dbReference>
<dbReference type="DrugBank" id="DB01865">
<property type="generic name" value="3-(6-Aminopyridin-3-Yl)-N-Methyl-N-[(1-Methyl-1h-Indol-2-Yl)Methyl]Acrylamide"/>
</dbReference>
<dbReference type="DrugBank" id="DB03534">
<property type="generic name" value="3-[(Acetyl-Methyl-Amino)-Methyl]-4-Amino-N-Methyl-N-(1-Methyl-1h-Indol-2-Ylmethyl)-Benzamide"/>
</dbReference>
<dbReference type="DrugBank" id="DB03030">
<property type="generic name" value="4-(2-Thienyl)-1-(4-Methylbenzyl)-1h-Imidazole"/>
</dbReference>
<dbReference type="DrugBank" id="DB08605">
<property type="generic name" value="6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL"/>
</dbReference>
<dbReference type="DrugBank" id="DB02379">
<property type="generic name" value="Beta-D-Glucose"/>
</dbReference>
<dbReference type="DrugBank" id="DB01691">
<property type="generic name" value="Indole Naphthyridinone"/>
</dbReference>
<dbReference type="DrugBank" id="DB08604">
<property type="generic name" value="Triclosan"/>
</dbReference>
<dbReference type="DrugCentral" id="P0AEK4"/>
<dbReference type="SwissLipids" id="SLP:000001775"/>
<dbReference type="SWISS-2DPAGE" id="P0AEK4"/>
<dbReference type="EPD" id="P0AEK4"/>
<dbReference type="jPOST" id="P0AEK4"/>
<dbReference type="PaxDb" id="P0AEK4"/>
<dbReference type="PRIDE" id="P0AEK4"/>
<dbReference type="EnsemblBacteria" id="AAC74370">
<property type="protein sequence ID" value="AAC74370"/>
<property type="gene ID" value="b1288"/>
</dbReference>
<dbReference type="EnsemblBacteria" id="BAA14841">
<property type="protein sequence ID" value="BAA14841"/>
<property type="gene ID" value="BAA14841"/>
</dbReference>
<dbReference type="GeneID" id="945870"/>
<dbReference type="KEGG" id="ecj:JW1281"/>
<dbReference type="KEGG" id="eco:b1288"/>
<dbReference type="PATRIC" id="fig|1411691.4.peg.991"/>
<dbReference type="EchoBASE" id="EB1490"/>
<dbReference type="EcoGene" id="EG11528">
<property type="gene designation" value="fabI"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG4105CSJ">
<property type="taxonomic scope" value="Bacteria"/>
</dbReference>
<dbReference type="eggNOG" id="COG0623">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="InParanoid" id="P0AEK4"/>
<dbReference type="KO" id="K00208"/>
<dbReference type="PhylomeDB" id="P0AEK4"/>
<dbReference type="BioCyc" id="EcoCyc:ENOYL-ACP-REDUCT-NADH-MONOMER"/>
<dbReference type="BioCyc" id="ECOL316407:JW1281-MONOMER"/>
<dbReference type="BioCyc" id="MetaCyc:ENOYL-ACP-REDUCT-NADH-MONOMER"/>
<dbReference type="BRENDA" id="1.3.1.9">
<property type="organism ID" value="2026"/>
</dbReference>
<dbReference type="SABIO-RK" id="P0AEK4"/>
<dbReference type="UniPathway" id="UPA00078"/>
<dbReference type="UniPathway" id="UPA00094"/>
<dbReference type="EvolutionaryTrace" id="P0AEK4"/>
<dbReference type="PRO" id="PR:P0AEK4"/>
<dbReference type="Proteomes" id="UP000000318">
<property type="component" value="Chromosome"/>
</dbReference>
<dbReference type="Proteomes" id="UP000000625">
<property type="component" value="Chromosome"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="EcoCyc"/>
</dbReference>
<dbReference type="GO" id="GO:0016020">
<property type="term" value="C:membrane"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004318">
<property type="term" value="F:enoyl-[acyl-carrier-protein] reductase (NADH) activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016631">
<property type="term" value="F:enoyl-[acyl-carrier-protein] reductase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="EcoCyc"/>
</dbReference>
<dbReference type="GO" id="GO:0009102">
<property type="term" value="P:biotin biosynthetic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030497">
<property type="term" value="P:fatty acid elongation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008610">
<property type="term" value="P:lipid biosynthetic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="EcoCyc"/>
</dbReference>
<dbReference type="GO" id="GO:0051289">
<property type="term" value="P:protein homotetramerization"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046677">
<property type="term" value="P:response to antibiotic"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="CDD" id="cd05372">
<property type="entry name" value="ENR_SDR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR014358">
<property type="entry name" value="Enoyl-ACP_Rdtase_NADH"/>
</dbReference>
<dbReference type="InterPro" id="IPR036291">
<property type="entry name" value="NAD(P)-bd_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR002347">
<property type="entry name" value="SDR_fam"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR43159:SF2">
<property type="entry name" value="PTHR43159:SF2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF000094">
<property type="entry name" value="Enoyl-ACP_rdct"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00081">
<property type="entry name" value="GDHRDH"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF51735">
<property type="entry name" value="SSF51735"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0046">Antibiotic resistance</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0275">Fatty acid biosynthesis</keyword>
<keyword id="KW-0276">Fatty acid metabolism</keyword>
<keyword id="KW-0444">Lipid biosynthesis</keyword>
<keyword id="KW-0443">Lipid metabolism</keyword>
<keyword id="KW-0520">NAD</keyword>
<keyword id="KW-0560">Oxidoreductase</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<feature type="initiator methionine" description="Removed" evidence="13 20 22">
<location>
<position position="1"/>
</location>
</feature>
<feature type="chain" description="Enoyl-[acyl-carrier-protein] reductase [NADH] FabI" id="PRO_0000054899">
<location>
<begin position="2"/>
<end position="262"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="NAD" evidence="6 7 8 9 10 11 12 19">
<location>
<begin position="19"/>
<end position="20"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="NAD" evidence="6 7 8 9 10 11 12 19">
<location>
<begin position="64"/>
<end position="65"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="NAD" evidence="6 7 8 9 10 11 12 19">
<location>
<begin position="192"/>
<end position="196"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="5">
<location>
<position position="146"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="5">
<location>
<position position="156"/>
</location>
</feature>
<feature type="binding site" description="NAD; via carbonyl oxygen" evidence="6 7 8 9 10 11 12 19">
<location>
<position position="13"/>
</location>
</feature>
<feature type="binding site" description="NAD" evidence="6 7 8 9 10 11 12 19">
<location>
<position position="40"/>
</location>
</feature>
<feature type="binding site" description="NAD; via carbonyl oxygen" evidence="6 7 8 9 10 11 12 19">
<location>
<position position="92"/>
</location>
</feature>
<feature type="binding site" description="Substrate; via amide nitrogen and carbonyl oxygen">
<location>
<position position="95"/>
</location>
</feature>
<feature type="binding site" description="NAD" evidence="6 7 8 9 10 11 12 19">
<location>
<position position="163"/>
</location>
</feature>
<feature type="site" description="Involved in acyl-ACP binding">
<location>
<position position="201"/>
</location>
</feature>
<feature type="site" description="Involved in acyl-ACP binding">
<location>
<position position="204"/>
</location>
</feature>
<feature type="site" description="Involved in acyl-ACP binding">
<location>
<position position="205"/>
</location>
</feature>
<feature type="mutagenesis site" description="Diazaborine resistance." evidence="13 21">
<original>G</original>
<variation>S</variation>
<location>
<position position="93"/>
</location>
</feature>
<feature type="mutagenesis site" description="Triclosan resistance." evidence="13 21">
<original>G</original>
<variation>V</variation>
<location>
<position position="93"/>
</location>
</feature>
<feature type="mutagenesis site" description="Large impact on catalysis, with kcat and kcat/Km for DD-ACP decreasing by around 50-fold compared with wild-type." evidence="14">
<original>Y</original>
<variation>F</variation>
<location>
<position position="146"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on substrate reduction." evidence="14">
<original>Y</original>
<variation>F</variation>
<location>
<position position="156"/>
</location>
</feature>
<feature type="mutagenesis site" description="Triclosan resistance." evidence="21">
<original>M</original>
<variation>T</variation>
<location>
<position position="159"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on substrate reduction." evidence="14">
<original>K</original>
<variation>A</variation>
<location>
<position position="201"/>
</location>
</feature>
<feature type="mutagenesis site" description="Little activity toward DD-CoA and DD-ACP." evidence="14">
<original>K</original>
<variation>E</variation>
<location>
<position position="201"/>
</location>
</feature>
<feature type="mutagenesis site" description="Triclosan resistance." evidence="21">
<original>F</original>
<variation>L</variation>
<location>
<position position="203"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on substrate reduction." evidence="14">
<original>R</original>
<variation>A</variation>
<location>
<position position="204"/>
</location>
</feature>
<feature type="mutagenesis site" description="Causes a further reduction in kcat/Km for reduction of DD-ACP without affecting kcat/Km for the DD-CoA substrate." evidence="14">
<original>R</original>
<variation>E</variation>
<location>
<position position="204"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on substrate reduction." evidence="14">
<original>K</original>
<variation>A</variation>
<location>
<position position="205"/>
</location>
</feature>
<feature type="mutagenesis site" description="Causes a further reduction in kcat/Km for reduction of DD-ACP without affecting kcat/Km for the DD-CoA substrate. Has a larger impact on substrate reduction." evidence="14">
<original>K</original>
<variation>E</variation>
<location>
<position position="205"/>
</location>
</feature>
<feature type="mutagenesis site" description="Produces temperature-sensitive phenotype.">
<original>S</original>
<variation>F</variation>
<location>
<position position="241"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="3"/>
<end position="6"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="8"/>
<end position="11"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="16"/>
<end position="19"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="20"/>
<end position="30"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="34"/>
<end position="41"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="42"/>
<end position="44"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="45"/>
<end position="54"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="60"/>
<end position="62"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="68"/>
<end position="79"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="83"/>
<end position="90"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="97"/>
<end position="100"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="101"/>
<end position="103"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="104"/>
<end position="107"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="110"/>
<end position="120"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="122"/>
<end position="131"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="132"/>
<end position="134"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="135"/>
<end position="145"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="147"/>
<end position="149"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="154"/>
<end position="157"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="158"/>
<end position="177"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="178"/>
<end position="181"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="182"/>
<end position="189"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="197"/>
<end position="199"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="200"/>
<end position="202"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="203"/>
<end position="213"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="222"/>
<end position="232"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="235"/>
<end position="237"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="244"/>
<end position="248"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="251"/>
<end position="253"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1DFI"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1MFP"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1QSG"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4JX8"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000250"/>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10201369"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10398587"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10493822"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10595560"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11514139"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12109908"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12699381"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1364817"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17012233"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19959361"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20693992"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7592873"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8119879"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8953047"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9298646"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9707111"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source ref="8"/>
</evidence>
<evidence key="23" type="ECO:0000305"/>
<sequence length="262" mass="27864" checksum="436A89AF349D1866" modified="2007-01-23" version="2">MGFLSGKRILVTGVASKLSIAYGIAQAMHREGAELAFTYQNDKLKGRVEEFAAQLGSDIVLQCDVAEDASIDTMFAELGKVWPKFDGFVHSIGFAPGDQLDGDYVNAVTREGFKIAHDISSYSFVAMAKACRSMLNPGSALLTLSYLGAERAIPNYNVMGLAKASLEANVRYMANAMGPEGVRVNAISAGPIRTLAASGIKDFRKMLAHCEAVTPIRRTVTIEDVGNSAAFLCSDLSAGISGEVVHVDGGFSIAAMNELELK</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>